Related Experiment Video
Updated: Aug 10, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response
Yue Wang1, Naoya Kato, Amarsanaa Jazag
1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. euy-tokyo@umin.ac.jp
Background & Aims:
Persistent infection with hepatitis C virus (HCV) leads to chronic hepatitis and hepatocellular carcinoma (HCC). RNA interference (RNAi) may act as a host antiviral response against viral RNA.
Methods:
The effects of RNAi on both the replicative intermediates and the internal ribosome entry site (IRES) of HCV were studied by using HCV-related short interfering RNA (siRNA) detection assay. The mechanism that permits HCV to escape RNAi was studied by using RNAi assay materials.
Results:
These studies demonstrate that the Dicer, an RNase enzyme that generates short siRNA, can target and digest both the IRES and the replicative intermediate of HCV into siRNA of approximately 22 nucleotides. Further studies also show that Dicer can inhibit the replication of the HCV subgenomic replicon. However, the HCV core protein inhibits this RNAi and rescues the replication of the HCV subgenomic replicon through a direct interaction with Dicer.
Conclusions:
RNAi is a limiting factor for HCV infection, and the core protein suppresses the RNA silencing-based antiviral response. This ability of the core protein to counteract the host defense may lead to a persistent viral infection and may contribute to the pathogenesis of HCV.
Insights
Hepatitis C virus (HCV) infection persistence is limited by RNA interference (RNAi). However, HCV core protein suppresses this antiviral response, potentially leading to chronic infection and disease.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Persistent Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis and hepatocellular carcinoma (HCC).
- RNA interference (RNAi) represents a potential host defense mechanism against viral RNA replication.
Purpose of the Study:
- To investigate the role and mechanism of RNA interference (RNAi) in controlling Hepatitis C virus (HCV) replication.
- To elucidate how HCV evades the host's RNAi antiviral response.
Main Methods:
- Utilized short interfering RNA (siRNA) detection assays to assess RNAi effects on HCV replicative intermediates and the internal ribosome entry site (IRES).
- Employed RNAi assays to study the mechanisms by which HCV escapes RNAi-mediated inhibition.
Main Results:
- The enzyme Dicer effectively targets and processes HCV IRES and replicative intermediates into approximately 22-nucleotide siRNA, inhibiting viral replication.
- HCV core protein was found to directly interact with Dicer, thereby inhibiting RNAi and rescuing viral replication.
Conclusions:
- RNAi acts as a critical limiting factor in HCV infection.
- HCV core protein actively suppresses the host's RNA silencing antiviral response.
- This suppression of host defense by the core protein may drive persistent HCV infection and contribute to viral pathogenesis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors

